| scholarly article | Q13442814 |
| P2093 | author name string | Deubel V | |
| Delenda C | |||
| Cabanié L | |||
| Staropoli I | |||
| Frenkiel MP | |||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Dengue virus | Q476209 |
| P304 | page(s) | 1569-1578 | |
| P577 | publication date | 1994-07-01 | |
| P1433 | published in | Journal of General Virology | Q6295245 |
| P1476 | title | Analysis of C-terminally truncated dengue 2 and dengue 3 virus envelope glycoproteins: processing in insect cells and immunogenic properties in mice | |
| P478 | volume | 75 ( Pt 7) |
| Q37812291 | A molecular evaluation of dengue virus pathogenesis and its latest vaccine strategies |
| Q27478104 | An adenovirus prime/plasmid boost strategy for induction of equipotent immune responses to two dengue virus serotypes |
| Q34540907 | C-terminal helical domains of dengue virus type 4 E protein affect the expression/stability of prM protein and conformation of prM and E proteins |
| Q35964754 | Dengue vaccine: priorities and progress |
| Q33678555 | Dengue virus type 3, South Pacific Islands, 2013. |
| Q27473186 | Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus |
| Q35625036 | Formalin-inactivated whole virus and recombinant subunit flavivirus vaccines |
| Q42990034 | Immune mediated and inherited defences against flaviviruses |
| Q40413896 | Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice |
| Q40428119 | Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen |
| Q40474022 | Induction of neutralizing antibodies and T cell responses by dengue virus type 2 envelope domain III encoded by plasmid and adenoviral vectors. |
| Q27480738 | Multiple specificities in the murine CD4+ and CD8+ T-cell response to dengue virus |
| Q40708505 | Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells |
| Q37346709 | Proteomic identification of dengue virus binding proteins in Aedes aegypti mosquitoes and Aedes albopictus cells |
| Q27480299 | Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form |
| Q33222362 | Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen |
| Q37903445 | The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease |
| Q33999741 | Use of recombinant envelope proteins for serological diagnosis of Dengue virus infection in an immunochromatographic assay |
Search more.